📰 Michael Erman Editing News
Michael Erman Editing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Erman Editing. Real-time updates on events, politics, business and more.
April 9, 2024
Pfizer said on Tuesday its respiratory syncytial virus vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60 similar to that in older adults,...
February 28, 2024
COVID-19 vaccine maker Novavax on Wednesday said it expects revenue this year to be flat or lower as it works to improve its commercial performance and pick up market share from much larger rivals,...
January 8, 2024
Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief...
December 29, 2023
Drugmakers including Pfizer , Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 unique drugs in early January, according to data analyzed by healthcare...
June 30, 2023
The U.S. government on Friday revised its guidance for its Medicare drug price negotiation process, allowing drug companies to publicly discuss the talks, but did not make major changes likely to convince drugmakers to end their suits seeking to halt the program.
May 31, 2023
(Reuters) -Swiss drugmaker Roche Holding AG plans to sell its 800-employee drug manufacturing plant in Vacaville, California, or it will shut the factory by 2029, according to e-mailed letters to workers seen by Reuters on Wednesday. | 06:20pm
May 31, 2023
(Reuters) -Swiss drugmaker Roche Holding AG plans to sell its 800-employee drug manufacturing plant in Vacaville, California, or it will shut the factory by 2029, according to e-mailed letters to workers seen by Reuters on Wednesday. | 06:20pm
February 18, 2021
UPDATE 1-Pfizer plans to test COVID-19 vaccine booster targeting the South African variant Reuters 2/18/2021 By Michael Erman NEW YORK, Feb 18 (Reuters) - A top Pfizer Inc scientist said on Thursday the company is in intensive discussions with regulators to test a booster shot version of its coronavirus vaccine specifically targeted for a highly contagious variant that is spreading widely in South Africa and elsewhere. A laboratory study released on Wednesday suggested that the South African ...